Trade AstraZeneca PLC - SEK - AZNs
AstraZeneca is a multinational biopharmaceutical company that resulted from the merger between the Swedish Astra AB and the English Zeneca Group in 1999. The company is engaged in developing and manufacturing products to treat oncology, cardiovascular & metabolic disease (CVMD) and pursues therapies in autoimmunity, infection and neuroscience. Its R&D headquarters are located in Warsaw, Poland, while its corporate base is in London, England. AstraZeneca is listed on the stock exchanges in London, New York and Stockholm under the ticker AZN. The AZN stock belongs to the FTSE 100 Index. Follow the latest developments of the AstraZeneca share price at Capital.com.Latest shares articles

Allianz stock forecast: record H1 profit, Q3 earnings ahead
Allianz is a German insurer whose shares are trading near record levels following record first-half operating profit and reports of a possible €5.8 billion acquisition of AA. Explore third-party ALV targets and technicals. Past performance is not a reliable indicator of future results.
11 hours ago

Assicurazioni Generali stock forecast: rising bond yields, ECB outlook
Generali is an Italian insurer listed in Milan, with its shares recently trading amid rising eurozone bond yields and wider financial-sector activity in Italy. Explore third-party G price targets and technical analysis. Past performance is not a reliable indicator of future results.
16 hours ago

Amplifon stock forecast: H1 growth and margin outlook
Amplifon is an Italian hearing-care company listed on Borsa Italiana. Its pending GN Hearing acquisition remains a key focus as investors assess potential effects on growth, margins and debt. Explore third-party AMP price targets. Past performance is not a reliable indicator of future results.
17 hours ago

Uber Technologies stock forecast: 3,300 job cuts, robotaxi push
Uber is cutting around 3,300 jobs as part of a restructuring, while expanding its autonomous-vehicle partnerships amid growing competition in the robotaxi market. Explore third-party UBER price targets and technical analysis. Past performance is not a reliable indicator of future results.
13:42, 29 September 2026
Related News
Reuters News•Europe
GlobeNewswire•Europe
Public Technologies•Europe